Sangamo BioSciences, Inc. (SGMO) Exec VP & CFO Henry Ward Wolff sells 10,000 Shares

Exec VP & CFO of Sangamo BioSciences, Inc. (SGMO, Financial) Henry Ward Wolff sells 10,000 shares of SGMO on 01/23/2013 at an average price of $10 a share.

Sangamo Biosciences, Inc. has a market cap of $518.8 million; its shares were traded at around $9.79 with and P/S ratio of 29.5. Sangamo Biosciences, Inc. had an annual average earning growth of 1.6% over the past 5 years.

CFO Recent Trades:

  • Exec VP & CFO Henry Ward Wolff sold 10,000 shares of SGMO stock on 01/23/2013 at the average price of 10. Henry Ward Wolff owns at least 209,219 shares after this. The price of the stock has decreased by 2.1% since.

Directors and Officers Recent Trades:

  • Vice President, Research & CSO Philip D Gregory sold 6,000 shares of SGMO stock on 01/02/2013 at the average price of 6.05. Philip D Gregory owns at least 90,000 shares after this. The price of the stock has increased by 61.82% since.
  • VP, Therapeutic Dev. & CMO Dale G Ando sold 17,000 shares of SGMO stock on 12/26/2012 at the average price of 5.92. Dale G Ando owns at least 88,798 shares after this. The price of the stock has increased by 65.37% since.
  • Vice President, Research & CSO Philip D Gregory sold 24,000 shares of SGMO stock on 12/10/2012 at the average price of 5.46. Philip D Gregory owns at least 90,000 shares after this. The price of the stock has increased by 79.3% since.
  • Director John William Larson sold 15,000 shares of SGMO stock on 12/03/2012 at the average price of 5.64. John William Larson owns at least 208,160 shares after this. The price of the stock has increased by 73.58% since.
  • VP, Therapeutic Dev. & CMO Dale G Ando sold 19,736 shares of SGMO stock on 11/27/2012 at the average price of 5.53. Dale G Ando owns at least 55,798 shares after this. The price of the stock has increased by 77.03% since.


For the complete insider trading history of SGMO, click here.